Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout
Viatris Inc. faced a securities fraud lawsuit due to alleged false statements about its India facility. The FDA's actions led to a stock price drop, impacting revenue. Investors can join the lawsuit until June 3, 2025. Consider other AI stocks for potential returns.